Sleep architecture in patients with interstitial lung disease with and without pulmonary hypertension

被引:2
作者
Simonson, Joseph L. [1 ]
Pandya, Dhwani [2 ]
Khan, Sarah [1 ]
Verma, Sameer [1 ]
Greenberg, Harly E. [1 ]
Talwar, Arunabh [1 ]
机构
[1] Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Med, Div Pulm Crit Care & Sleep Med, 410 Lakeville Rd,Suite 107, New Hyde Pk, NY 10040 USA
[2] Northwell Hlth Staten Isl Univ Hosp, Dept Med, 475 Seaview Ave, Staten Isl, NY 10305 USA
关键词
Interstitial lung disease; Nocturnal hypoxemia; Obstructive sleep apnea; Pulmonary hypertension; Sleep-disordered breathing;
D O I
10.1007/s11325-021-02555-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose Sleep disturbance is common in patients with advanced interstitial lung disease (ILD) often complicated by pulmonary hypertension (PH) and may contribute to poor quality of life. The etiology of sleep disturbance and the relationship between PH and sleep architecture in patients with ILD remains unknown. Methods We performed a retrospective cohort study comparing sleep architecture on polysomnography in patients with ILD with and without PH, defined as mean pulmonary artery pressure on right heart catheterization >= 20 mmHg. We tested the hypothesis that patients with ILD and PH would have increased wake time after sleep onset (WASO) compared to patients with ILD without PH using univariate analysis and multivariable linear regression. Results In our cohort of patients with ILD who underwent polysomnography (N = 49), patients with PH had lower total diffusion capacity for carbon monoxide (DLCO) (9.28 vs. 12.87 ml/min/mmHg, P = 0.04) and percent DLCO (39% vs. 53%, P = 0.03). On polysomnography, patients with PH had increased percentage of total sleep time with saturation < 90% (T90) (17% vs. 6%, P = 0.03), decreased N2 sleep (181 vs. 233 min, P = 0.03), decreased %N2 sleep (59% vs. 66%, P = 0.04), increased %N1 sleep (22% vs. 14%, P = 0.02), decreased sleep efficiency (62% vs. 72%, P = 0.03), and increased WASO (133 vs. 84 min, P = 0.01). In multivariable analysis, PH was associated with a 43-min increase in WASO (95% CI 6.2-80.2, P = 0.02). Conclusion Patients with ILD and PH have decreased total and %N2 sleep, increased %N1 sleep, decreased sleep efficiency, and increased WASO, likely indicating increased sleep fragmentation.
引用
收藏
页码:1711 / 1715
页数:5
相关论文
共 50 条
  • [21] Baseline characteristics and survival of patients with pulmonary hypertension in interstitial lung disease in the "HYPID" study
    Cottin, Vincent
    Reynaud-Gaubert, Martine
    Nunes, Hilario
    Montani, David
    Wallaert, Benoit
    Camara, Boubou
    Khouatra, Chahera
    Israel-Biet, Dominique
    Uzunhan, Yuerdagul
    Gomez, Emmanuel
    Marchand-Adam, Sylvain
    Nieves, Ana
    Jais, Xavier
    Wemeau-Stervinou, Lidwine
    Traclet, Julie
    Launay, David
    Dromer, Claire
    Magnier, Romain
    Prevot, Gregoire
    Polazzi, Stephanie
    Zeghmar, Sabrina
    Schott, Anne-Marie
    Humbert, Marc
    Cordier, Jean-Francois
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [22] Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease A Multidisciplinary Delphi Study
    Rahaghi, Franck F.
    Kolaitis, Nicholas A.
    Adegunsoye, Ayodeji
    de Andrade, Joao A.
    Flaherty, Kevin R.
    Lancaster, Lisa H.
    Lee, Joyce S.
    Levine, Deborah J.
    Preston, Ioana R.
    Safdar, Zeenat
    Saggar, Rajan
    Sahay, Sandeep
    Scholand, Mary Beth
    Shlobin, Oksana A.
    Zisman, David A.
    Nathan, Steven D.
    [J]. CHEST, 2022, 162 (01) : 145 - 155
  • [23] Management of pulmonary hypertension resulting from interstitial lung disease
    Shapiro, S
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2003, 9 (05) : 426 - 430
  • [24] Converging Pathways: A Review of Pulmonary Hypertension in Interstitial Lung Disease
    Lawrence, Alexandra
    Myall, Katherine Jane
    Mukherjee, Bhashkar
    Marino, Philip
    [J]. LIFE-BASEL, 2024, 14 (09):
  • [25] Pulmonary Hypertension and Lung Transplant in Connective Tissue Disease-Interstitial Lung Disease
    Melendres-Groves, Lana
    Vazquez-Guillamet, Rodrigo
    Dhillon, Gundeep
    [J]. CURRENT RESPIRATORY MEDICINE REVIEWS, 2015, 11 (02) : 156 - 162
  • [26] Pulmonary hypertension in interstitial lung disease: screening, diagnosis and treatment
    Behr, Juergen
    Nathan, Steven D.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2021, 27 (05) : 396 - 404
  • [27] Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial
    Hoeper, Marius M.
    Halank, Michael
    Wilkens, Heinrike
    Guenther, Andreas
    Weimann, Gerrit
    Gebert, Irmingard
    Leuchte, Hanno H.
    Behr, Juergen
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (04) : 853 - 860
  • [28] Impact of pulmonary hypertension on exercise performance in patients with interstitial lung disease undergoing evaluation for lung transplantation
    Armstrong, Hilary F.
    Schulze, P. Christian
    Bacchetta, Matthew
    Thirapatarapong, Wilawan
    Bartels, Matthew N.
    [J]. RESPIROLOGY, 2014, 19 (05) : 675 - 682
  • [29] Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity
    Michelfelder, M.
    Becker, M.
    Riedlinger, A.
    Siegert, E.
    Droemann, D.
    Yu, X.
    Petersen, F.
    Riemekasten, G.
    [J]. CLINICAL RHEUMATOLOGY, 2017, 36 (02) : 381 - 390
  • [30] Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity
    M. Michelfelder
    M. Becker
    A. Riedlinger
    E. Siegert
    D. Drömann
    X. Yu
    F. Petersen
    G. Riemekasten
    [J]. Clinical Rheumatology, 2017, 36 : 381 - 390